Trusted by over 100K subscribers
100% online process
No memberships requirements
Transparent pricing, no hidden fees
Board certified physicians
US sourced ingredients
Foundayo® Oral Safety Information
Foundayo® oral contains Tirzepatide, a dual GIP and GLP-1 receptor agonist. It is taken once daily by mouth and is distinct from injectable Tirzepatide formulations in its method of administration.
Warning: Risk of Thyroid C-Cell Tumors
In studies in rodents, tirzepatide caused thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). It is unknown whether Tirzepatide causes thyroid C-cell tumors, including MTC, in humans.
Do not use Foundayo® if:
Tell your provider right away if you experience:
These may be symptoms of thyroid cancer.
What Is Foundayo® Used For?
Foundayo® is prescribed, along with a reduced-calorie diet and increased physical activity, to:
Help reduce excess body weight and maintain weight loss long-term in adults with:
Important Differences: Oral vs. Injectable Tirzepatide
Both formulations contain Tirzepatide and share similar safety warnings and contraindications. Dosing schedules, titration plans, and administration instructions differ. Follow your provider's guidance carefully.
Do Not Use Foundayo® With
Who Should Not Use Foundayo®?
Do not use if:
Before Taking Foundayo®, Tell Your Provider If You:
Pregnancy & Reproductive Planning
Foundayo® should not be used during pregnancy.
Stop Foundayo® at least 2 months before a planned pregnancy.
There is no benefit to weight loss during pregnancy and it may harm an unborn baby.
Drug Interactions
Foundayo® oral may affect how other oral medications are absorbed.
Tell your provider if you take:
Serious Side Effects
Seek medical attention immediately if you experience symptoms of:
Most Common Side Effects
Side effects are most common during dose escalation.
Additional Safety Notes